In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other undervalued stocks. On March 5th, BBC reported that the US stock market had fallen after the ...

As Roche heads towards an FDA verdict on its CD20xCD3 bispecific Lunsumio for lymphoma before the end of this year, rivals from Regeneron and AbbVie are starting to nip at its heels, with new ...

In early February, Amgen released financial results for the 4th quarter of 2024, which I was eagerly awaiting. In addition to demonstrating efficacy in the treatment of nasal polyps in Phase 3 ...

The FDA has approved AstraZeneca and Amgen's severe asthma hope tezepelumab, exonerating the drugmakers' decision to press ahead with a regulatory filing despite a failed phase 3 trial.

Hyderabad: America's largest biotechnology company Amgen (AMGEN) launched its new technology and innovation site in Hyderabad on Monday. Chief Minister A Revanth Reddy and IT and Industries ...

Speaking as the chief guest at the inauguration of Amgen India’s new office in Raheja Knowledge City, Raidurg, on Monday, the minister emphasised that Hyderabad represents the future. The employees at ...

Global biotech leader Amgen opened its $200 million technology and innovation centre in Hyderabad, a facility that will help the U.S. firm ramp up digital capabilities, open more opportunities for ...

US drug major Amgen on Monday announced the opening of its new technology and innovation site in Hyderabad. The company said it plans to invest $200 million through 2025, with additional ...

Amgen will invest $200 million in its new technology centre in Hyderabad, India, this year, with plans for further investments. The centre, focused on AI and data science for drug development, will ...